Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
Ronald Tutrone(The University of Texas System), Neal D. Shore(Carolina Urologic Research Center), Sarah Hanson(University of East Anglia), Daniel J. George(Duke University), Michael S. Cookson(University of Oklahoma Health Sciences Center), Fred Saad(Centre Hospitalier de l’Université de Montréal), Sophia Lu(Myovant Sciences (United States)), Mark Fallick(Myovant Sciences (United States)), Daniel R. Saltzstein(Urology San Antonio), Bertrand Tombal(Cliniques Universitaires Saint-Luc), James L. Bailen(Urology of Indiana), Bruce Alan Brown(Myovant Sciences (United States))
Cited by 21
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k